The various aspects related to ovarian cancer
In any type of cancer early diagnosis is critical to the success of treatment.
It will depend on the results obtained, especially in cases of malignant tumors. Ovarian cancer, one of the worst prognosis, evolve in a certain way depending on the stage where it is detected.
Dr. Jose Angel Arranz, head of the unit of urological and gynecological tumors and section chief of oncology at Hospital Gregorio Marañón in Madrid, we expose in detail the various aspects related to ovarian cancer. Risk factors for developing ovarian cancer different factors are known to influence the development of ovarian cancer.
The genetic factor may be key. Some genetic disorders can cause mutation and make us more willing to suffer this type of tumor. It is therefore very important to know the family history and make a very close medical supervision. Anyway, this risk only occurs in 10% of cases. Elsewhere, the occurrence of ovarian cancer is accidental and has no factor directly related, although the use of contraceptives ovarian or obesity can exert a minimal influence. Can we prevent ovarian cancer? The truth is that there is a specific way to prevent ovarian cancer. Thus it is necessary to sensitize the female population from age 40, or the onset of menopause, undergo vaginal controls the periodicity recommended by the gynecologist. This is the way to detect abnormal cells and reach the most time possible to treat the tumor.
Which protocol to follow when diagnosing an ovarian cancer diagnosis in any ovarian cancer treatment goes to undergo surgery. This is a radical treatment which removes the uterus and ovaries, the authors reviewed the entire abdominal cavity through a biopsy and review the suspicious areas of the body. In early stages of Level 1 and 2, surgery is almost guaranteed cure, although in some cases are necessary round of chemotherapy. After surgery, the tumor can recur? The answer is yes. Relapses were defined according to the cycle that runs from the last session of chemotherapy. If the cancer comes back before 6 months is considered early, whereas if the time is superior, we are talking about a late relapse. In cases of recurrent tumors there are many treatment options.
You can choose to rescue medication or surgical standard. When we refer to late tumors, the combination of drugs is more effective than monotherapy. In fact, with treatments based on these combinations, survival rates have increased. Are emerging studies that show benefits of new drugs being developed. In the past 5 years have seen some medications that have demonstrated improvements in patients. Yondelis, the latest in Yondelis drug is a drug recently approved by the Medicines Agency which is a real novelty. Its effectiveness has been made compared to previously used drugs, and the results support the data that certify a progression-free survival of patients Polycystic Ovary, “higher-risk patients? The polycystic ovary is a benign disease that usually must not end in ovarian cancer. What it is true is that in some cases the cysts may be an ovarian tumor. This occurs in patients whose cysts have above measures 6cm (usually the size is 2 or 3 cm), had blood forming papillae. In these cases the cysts should be monitored closely and even remove them if necessary.
I think other website proprietors should take this website as an model, very clean and excellent user pleasant style .